In the Boardroom
Refine Search
Pharmaceutical
US pharma major Bristol-Myers Squibb has announced the appointment to the board of three new independent directors. 22 February 2017
Pharmaceutical
Teijin Pharma, the core company of Japan’s Teijin Group’s healthcare business, says that its board of directors has elected Akihisa Nabeshima as its next president. 22 February 2017
Pharmaceutical
A pharma veteran has switched from one of the industry’s giants to another to lead its UK pharmaceuticals business. 15 February 2017
Pharmaceutical
While last week’s news continued to be dominated by actions of newly-installed US President Donald Trump, including the vote to approve his controversial nominee Dr Tom Price as Secretary of Health and Human Services, the pharma industry itself was also making headlines. 12 February 2017
Pharmaceutical
Christine Lind has been appointed as the new chief executive of Swedish drugmaker Medivir. 9 February 2017
Biotechnology
Oxford BioTherapeutics (OBT) has added two new names to a board now boasting significant experience in developing immuno-oncology and antibody-based therapies. 9 February 2017
Biotechnology
Danish biotech firm Genmab has a third member of its executive team. 8 February 2017
Pharmaceutical
French drugmaker Ipsen has added years of big pharma experience to its executive and research and development (R&D) leadership teams. 7 February 2017
Generics
Erez Vigodman is stepping down from his post as chief executive of Teva Pharmaceutical Industries “by mutual agreement,” the Israeli generics giant announced late Monday. 7 February 2017
Biotechnology
France-based Nanobiotix has appointed Alain Dostie as its chief operating officer. 7 February 2017
Pharmaceutical
Thomas Cueni has taken up office as director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) on February 1, representing the interests of the research-based biopharmaceutical industry at a global level. 7 February 2017
Pharmaceutical
Sanofi today announces the appointment of Hugo Fry as general manager for the UK and general manager Sanofi Pasteur for the UK & Ireland, and Dr Hubert Bland as UK medical chair and medical head of diabetes and cardiovascular for the UK & Ireland. 1 February 2017
Pharmaceutical
French pharma major Sanofi today announced the appointment of Kathleen Tregoning as a new member of the executive committee, effective February 27, 2017. 30 January 2017
Biotechnology
US biotech firm Juno Therapeutics has appointed Corsee Sanders as executive vice president and head of development operations, effective immediately. 29 January 2017
Generics
On January 26, 2017, Dr Arie Belldegrun resigned as a member of the board of directors of Teva Pharmaceutical Industries, according to a company regulatory filing. 27 January 2017
Pharmaceutical
EMD Serono, the biopharmaceutical business of German pharma major Merck KGaA in the USA and Canada, has announced that Richard Smith has been appointed its head of US fertility and endocrinology. 25 January 2017
Biotechnology
Monoclonal antibody specialist Kymab has appointed Arndt Schottelius as its first executive vice president of research and development (R&D). 23 January 2017
Pharmaceutical
Harout Semerjian has been named Ipsen’s new head of specialty care, international region and global franchises. 20 January 2017
Pharmaceutical
Japanese drugmaker Sosei Group has announced that Andrew Oakley is to become its chief financial officer (CFO). 19 January 2017
Pharmaceutical
A major change at the top of GlaxoSmithKline’s pharmaceutical business has been announced as part of what has been described as ‘succession processes’ at the company. 19 January 2017
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze